The outbreak of meningitis due to Neisseria meningitidis W135 in 2003 in Burkina Faso and the national response: Main lessons learnt

Vaccine

Volumn 25, Issue SUPPL. 1, 2007, Pages

  Zombré, Sosthene ^a   Hacen, Mohamed Mahmoud ^b   Ouango, Gabriel ^a   Sanou, Souleymane ^a   Adamou, Yada ^c   Koumaré, Bréhima ^d   Kondé, Mandy Kader ^e  

^a Ministry of Health   (Burkina Faso)

^b WHO ^*  (Burkina Faso)

^c WHO Regional Office for Africa   (Zimbabwe)

^d WHO Inter Country Support Team   (Côte d’Ivoire)

^e WHO Country Office   (Burkina Faso)

Author keywords

Burkina Faso; Meningitis; Nm W135; Outbreak

Indexed keywords

ACW 135 VACCINE; MENINGITIS VACCINE; TRIPLE VACCINE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD GROUP TYPING; BURKINA FASO; HUMAN; MENINGITIS; MORBIDITY; MORTALITY; NEISSERIA MENINGITIDIS; NORWAY; PRIORITY JOURNAL; VACCINE PRODUCTION; WORLD HEALTH ORGANIZATION;

BURKINA FASO; DISEASE OUTBREAKS; FEDERAL GOVERNMENT; HUMANS; INFECTION CONTROL; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP W-135; WORLD HEALTH ORGANIZATION;

EID: 34547680085     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.044     Document Type: Article

References (13)

1. WHO. Prevention and control of epidemic meningococcal disease in Africa. Report of a WHO technical consultation meeting, Ouagadougou, Burkina Faso, 23-24 September 2002. Geneva: World Health Organization (WHO/CDS/CSR/GAR/2003.10) 2003.
2. WHO. Enhanced surveillance of epidemic meningococcal meningitis in Africa: a three-year experience. World Health Organ WER 16 September 2005; 80: 313-320. http://www.who.int/wer/2005/wer8037.pdf.
3. WHO, International Coordinating Group (ICG) on Vaccine Provision (1997). www.who.int/csr/disease/meningococcal/icg/en/.
4. WHO. Communicable Disease Surveillance and Response. Meningococcal disease surveillance in the African meningitis belt, Update 7. Geneva: World Health Organization WHO; 2001. http://www.who.int/disease-outbreak-news/n2001/april/23april2001.html.
5. Robbins J.B., Schneerson R., Gotschlich E.C., Mohammed I., Nasidi A., Chippaux J.-P., et al. Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines. Bull World Health Organ 81 10 (2003) 743-749
6. Birmingham M.E., Lewis R.F., Perea W., Nelson C.B., Kabore A., and Tarantola D. Routine vaccination with polysaccharide meningococcal vaccines is an ineffective and possibly harmful strategy. Bull World Health Organ 81 10 (2003) 751-755
7. Greenwood B. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg 93 (1999) 341-353
8. Greenwood B.M., Bradley A.K., and Wall R.A. Meningococcal disease and season in sub-Saharan Africa. Lancet 2 (1985) 829-830 8459
9. WHO. Meningococcal disease, serogroup W135, Wkly Epidemiol Rec 2001; 76: 141-148.
10. Perkins B.A., Broome C.V., Rosenstein N.E., Schuchat A., and Reingold A.L. Meningococcal vaccine in sub-Saharan Africa. Lancet 350 1708 (1997) 9092
11. Obaro S. Control of meningococcal disease in west Africa. Lancet 355 (2000 Apr 1) 1184-1185
12. Lapeyssonie L. La méningite cérébro-spinale en Afrique. Bull World Health Organ 28 Suppl (1963) 3-114
13. Ministère de la Santé du Burkina Faso,: Rapport de gestion de l'épidémie de méningite de 2003 au Burkina Faso, Juillet 2003.